Newton J R
Department of Obstetries and Gynacology, University of Birmingham, Birmingham Womens Hospital, Edgbaston, UK.
Baillieres Clin Obstet Gynaecol. 1996 Apr;10(1):87-101. doi: 10.1016/s0950-3552(96)80064-2.
Three types of new contraceptive delivery system have been discussed in this chapter. Each have novel methods of delivery and may be acceptable to certain groups of women. It is clear that subdermal contraceptive implants are extremely useful as a long-term method of contraception, and provided insertion occurs correctly, removal will then be easy. The second-generation implants using a single rod, compared with the first-generation ones using six capsules, would appear to offer advantages both to the patient and in relation to the training of medical and paramedical personnel who have to fit the subdermal implant. The main disadvantage is the incidence of irregular bleeding, which, by and large, can be overcome by pre-insertion counselling and by time. The second method of delivery, vaginal rings, offers high patient acceptability, but a usable ring for contraception has as yet to be developed. Two approaches appear to be the use of a continuous progestogen-only ring, or a combined ring releasing oestrogen and progestogen with a 21-day-in, 7-day-out cycle of use. Ongoing studies will indicate whether vaginal lesions are significant or related to the flexibility of the ring. If these studies prove satisfactory, further development of the vaginal rings, both as an alternative method for interval use or as a specific postpartum form of contraception using progesterone-releasing rings, will be developed. Significant developments in the use of a combined monthly injectable have led to the release of two preparations, Cyclofem and Mesigyna, which are now available in many countries. This combined approach offers a significant reduction in amenorrhoea rates and unacceptable bleeding, the majority of women having acceptable menstrual patterns even during the first 3 months of use. All three methods have low and acceptable rates of pregnancy, the lowest being seen with the subdermal implants and with combined monthly injectables. Due to the length of action of subdermal implants, these may find a niche for women wishing to use a long-acting method and not wishing to be sterilized. They also provide a useful method where medical intervention is not available on a regular basis. Monthly injectable preparations can be given by paramedical personnel, and introductory studies have indicated that in developing and developed countries, they are highly acceptable. All three methods offer an increased choice for women and safe and effective methods of contraception.
本章讨论了三种新型避孕给药系统。每种都有新颖的给药方法,可能会被某些女性群体所接受。皮下避孕植入物作为一种长效避孕方法非常有用,而且只要正确植入,取出就很容易。与使用六个胶囊的第一代皮下避孕植入物相比,使用单根棒的第二代植入物似乎对患者以及对必须植入皮下避孕植入物的医务人员和辅助医务人员的培训都有优势。主要缺点是不规则出血的发生率,不过大体上可以通过植入前咨询和时间来克服。第二种给药方法,阴道环,患者接受度高,但用于避孕的可用阴道环尚未研发出来。两种方法似乎是使用仅含孕激素的持续释放环,或使用含雌激素和孕激素且使用周期为21天置入、7天取出的复方环。正在进行的研究将表明阴道病变是否严重或与环的柔韧性有关。如果这些研究结果令人满意,阴道环作为一种间隔期使用的替代方法或作为使用释放孕激素环的特定产后避孕形式将得到进一步研发。复方每月注射剂的使用取得了重大进展,已推出两种制剂,环复新和美欣乐,现在许多国家都有供应。这种复方方法使闭经率和不可接受的出血情况大幅减少,大多数女性即使在使用的头三个月月经模式也可以接受。所有这三种方法的妊娠率都很低且可接受,皮下避孕植入物和复方每月注射剂的妊娠率最低。由于皮下避孕植入物作用时间长,对于希望使用长效方法且不希望绝育的女性来说,它们可能会有一席之地。在无法定期进行医疗干预的情况下,它们也是一种有用的方法。每月注射剂可由辅助医务人员给药,初步研究表明,在发展中国家和发达国家,它们都非常容易被接受。所有这三种方法为女性提供了更多选择以及安全有效的避孕方法。